### Dexcom's Advancements in Continuous Glucose Monitoring (CGM) Technology Dexcom has been a leader in continuous glucose monitoring (CGM) technology for many years. Since the launch of its first 3-day sensor in 2006, Dexcom has continuously innovated to provide better options for people with diabetes to monitor their blood sugar levels. Here are some key advancements: #### Dexcom G6 - **10-Day Wear Sensor**: The G6 sensor can be worn for 10 days and is more accurate and reliable than earlier models. However, it has a hard shutoff at the 10-day mark. - **No Fingerstick Calibration**: The G6 is FDA-approved for making insulin dosing decisions without the need for backup fingerstick tests. - **Disposable Auto Inserter**: The G6 comes with a spring-loaded auto-insertion device that makes it easy to insert a new sensor. - **Mobile App**: The G6 app works on both iPhone and Android, displaying real-time glucose levels and trends. It also allows data sharing with up to five people and healthcare providers. - **Alerts**: The G6 offers predictive alerts for low glucose levels and customizable alerts for different times of the day. - **No Tylenol Interference**: The G6 eliminates interference from medications containing acetaminophen. #### Upcoming Dexcom G7 - **Extended Wear**: The G7 will offer 14 to 15 days of wear, compared to the G6's 10 days. - **Fully Disposable**: The G7 will be fully disposable, integrating the sensor and transmitter into one unit. - **Thinner Design**: The G7 will be the thinnest CGM sensor yet. - **Decision-Support Features**: The G7 will include software features to help users make better health decisions based on their CGM readings. Dexcom continues to be a major player in the diabetes technology industry, working towards more advanced and user-friendly CGM systems.